​

Funding Round

Series C - Sphingotec GmbH

Series C - Sphingotec GmbH

Investment Firm

Overview

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Announced Date

Aug 08, 2024

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

Think.Health

Think.Health

Think.Health is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorThink.Health
Participant InvestorNRW.BANK
Participant InvestorHBM Healthcare Investments
Participant InvestorWellington Partners

Round Details and Background

Sphingotec GmbH raised $5469089 on 2024-08-08 in Series C

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 22, 2022
Convertible Note - Sphingotec GmbH
2-undefined
Jul 19, 2022
Series B - Sphingotec GmbH
1-undefined
Mar 14, 2023
Series B - Sphingotec GmbH
1-1.6M
Aug 08, 2024
Series C - Sphingotec GmbH
5-5.5M

Recent Activity

There is no recent news or activity for this profile.